Targeted innate immune inhibition therapy for treatment of recurrent acute cystitis

This capsule contains the data from a randomized phase 2 trial comparing the IL-1 receptor antagonist anakinra with nitrofurantoin in women with recurrent cystitis. It includes Acute Cystitis Symptom Scores, quality-of-life measures, white blood cell counts, and differential counts. The provided R script describes the analysis code for ordinal logistic mixed-effects and ART-ANOVA models and post-hoc comparisons. Associated clinical trial identifiers: DRKS00025964 and EudraCT 2019-004209-28.